BioAtla, Inc.BCABNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank33
3Y CAGR-41.5%
5Y CAGR+67.6%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-41.5%/yr
Annual compound
5Y CAGR
+67.6%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
13.2x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$49.05M-56.0%
2023$111.47M-48.3%
2022$215.51M-12.0%
2021$244.98M+2.7%
2020$238.60M+6341.8%
2019$3.70M-65.9%
2018$10.86M-